These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6127066)

  • 1. Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.
    Rajput AH; Rozdilsky B; Hornykiewicz O; Shannak K; Lee T; Seeman P
    Arch Neurol; 1982 Oct; 39(10):644-6. PubMed ID: 6127066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced parkinsonism in the elderly.
    Stephen PJ; Williamson J
    Lancet; 1984 Nov; 2(8411):1082-3. PubMed ID: 6150149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-induced Parkinsonism: Clinicopathological study.
    Shuaib UA; Rajput AH; Robinson CA; Rajput A
    Mov Disord; 2016 Mar; 31(3):360-5. PubMed ID: 26660063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid homovanillic acid and hypokinetic side effects of neuroleptics.
    Bowers MB
    Psychopharmacology (Berl); 1985; 85(2):184-6. PubMed ID: 2861619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.
    Bocola V; Fabbrini G; Sollecito A; Paladini C; Martucci N
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):213-6. PubMed ID: 8708659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selegiline for neuroleptic-induced parkinsonism.
    Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
    Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
    Ekdawi MY; Fowke R
    Br J Psychiatry; 1966 Jun; 112(487):633-6. PubMed ID: 5964267
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract]   [Full Text] [Related]  

  • 9. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
    Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
    Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
    Psychopharmacology (Berl); 1986; 90(4):423-9. PubMed ID: 2880362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuropharmacological and neuroendocrine study on idiopathic and chronic pharmacological Parkinsonism.
    Agnoli A; Ruggieri S; Falaschi P; Baldassarre M; D'Urso R; Forchetti C; Polleri A
    Adv Biochem Psychopharmacol; 1980; 24():551-7. PubMed ID: 6157311
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
    Rao JM; Cowie VA; Mathew B
    J Ment Defic Res; 1989 Feb; 33 ( Pt 1)():81-6. PubMed ID: 2564436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug induced parkinsonism: a common cause of parkinsonism in older people.
    Thanvi B; Treadwell S
    Postgrad Med J; 2009 Jun; 85(1004):322-6. PubMed ID: 19528308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment.
    Bowers MB; Heninger GR
    Psychiatry Res; 1981 Jun; 4(3):285-90. PubMed ID: 6115436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-DOPA on pharmacological parkinsonism.
    Bruno A; Bruno SC
    Acta Psychiatr Scand; 1966; 42(3):264-71. PubMed ID: 5335155
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of drugs used in psychoses on cerebral dopamine metabolism.
    O'Keeffe R; Sharman DF; Vogt M
    Br J Pharmacol; 1970 Feb; 38(2):287-304. PubMed ID: 4984801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
    Dhopesh V; Macfadden A; Maany I; Gamble G
    Psychiatr Serv; 1997 Jan; 48(1):95-7. PubMed ID: 9117510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacopsychiatry and iatrogenic parkinsonism].
    Pérez de Francisco C; Garnica Portillo R
    Neurol Neurocir Psiquiatr; 1978; 19(1):53-7. PubMed ID: 30054
    [No Abstract]   [Full Text] [Related]  

  • 19. Seborrheic dermatitis in neuroleptic-induced parkinsonism.
    Binder RL; Jonelis FJ
    Arch Dermatol; 1983 Jun; 119(6):473-5. PubMed ID: 6134496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
    Munhoz RP; Bertucci Filho D; Teive HA
    Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.